Free Float 100,00 %
Shares Float 24,75 M
Shares Outstanding 24,75 M
FIRST TRUST NASDAQ PHARMACEUTICALS ETF ETF · US33738R8372 · FTXH (XNAS) First Trust · TER 0,60 % · United States · Financial Services — real-time prices and quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of FIRST TRUST NASDAQ PHARMACEUTICALS ETF
No Price
19.08.2026 20:16
Current Prices from FIRST TRUST NASDAQ PHARMACEUTICALS ETF
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
 NASDAQ |
FTXH
|
USD
|
19.08.2026 20:16
|
43,00 USD
| 2,42 USD
+5,96 %
|
 IEX |
FTXH
|
USD
|
19.08.2026 19:59
|
42,58 USD
| 2,00 USD
+4,92 %
|
Share Float & Liquidity
Asset Allocation
| Asset | Percentage % |
|---|---|
| Equity | 99,86 % |
Largest Positions(51)
Updated on Aug 20 2026, 2:57 AM
| Symbol | ISIN | CUSIP | Name | Shares | Market Value | Percentage % |
|---|---|---|---|---|---|---|
| LLY | US5324571083 | 532457108 | Eli Lilly and Company | 62.260 | 76,31 M EUR | 7,48 % |
| ABBV | US00287Y1091 | 00287Y109 | AbbVie Inc. | 283.129 | 73,31 M EUR | 7,19 % |
| JNJ | US4781601046 | 478160104 | Johnson & Johnson | 264.551 | 71,72 M EUR | 7,03 % |
| MRK | US58933Y1055 | 58933Y105 | Merck & Co., Inc. | 530.619 | 71,72 M EUR | 7,03 % |
| BMY | US1101221083 | 110122108 | Bristol-Myers Squibb Company | 1,05 M IDX | 69,6 M EUR | 6,82 % |
| BIIB | US09062X1037 | 09062X103 | Biogen Inc. | 171.188 | 36,39 M EUR | 3,57 % |
| AMGN | US0311621009 | 031162100 | Amgen Inc. | 84.827 | 36,08 M EUR | 3,54 % |
| VTRS | US92556V1061 | 92556V106 | Viatris Inc. | 2,2 M IDX | 35,59 M EUR | 3,49 % |
| VRTX | US92532F1003 | 92532F100 | Vertex Pharmaceuticals Incorporated | 66.256 | 35 M EUR | 3,43 % |
| REGN | US75886F1075 | 75886F107 | Regeneron Pharmaceuticals, Inc. | 42.160 | 34,16 M EUR | 3,35 % |
Region Distribution
| Region | Percentage % |
|---|---|
| North America | 0,00 % |
| Europe | 0,00 % |
| Other | 0,00 % |
Country Distribution
| Country | Percentage % |
|---|---|
| USA | 95,61 % |
| Ireland | 3,68 % |
| United Kingdom and Northern Ireland | 0,57 % |
Sector Distribution
| Sector | Percentage % |
|---|---|
| Healthcare | 99,86 % |
Industry Distribution
| Industry | Percentage % |
|---|---|
| Drug Manufacturers - General | 38,54 % |
| Biotechnology | 22,43 % |
| Medical - Pharmaceuticals | 20,68 % |
| Medical - Diagnostics & Research | 7,08 % |
| Drug Manufacturers - Specialty & Generic | 6,75 % |
| Medical - Equipment & Services | 3,31 % |
| Medical - Healthcare Information Services | 1,07 % |
Currency Distribution
| Currency | Percentage % |
|---|---|
| USD | 97,44 % |
| EUR | 2,42 % |
Invested Funds
The following funds have invested in FIRST TRUST NASDAQ PHARMACEUTICALS ETF:
Fund | Vol. in million 559.944,92 | Percentage (%) 20,31 % |
Fund | Vol. in million 46.521,93 | Percentage (%) 20,31 % |
Company Profile for FIRST TRUST NASDAQ PHARMACEUTICALS ETF ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depository receipts that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and weighted based upon their cumulative score on three investing factors: volatility, value and growth. It is non-diversified.
Fund Master Data
Issuer First Trust
Asset Class ETF
Name First Trust Nasdaq Pharmaceuticals ETF
Asset Class Sector Equity
Fund Currency USD
Total Expense Ratio (TER) 0,60 %
Domicile United States
Website ftportfolios.com
Fund Key Figures
Fund Size 21.984,98 USD
NAV 39,12 USD
AUM 960,42 M USD
Avg. Daily Volume 561.727
Investment Strategy
The First Trust Nasdaq Pharmaceuticals ETF (FTXH) operates as an exchange-traded fund. Its primary aim is to mirror the financial performance—both capital appreciation and income generation—of the Nasdaq US Smart Pharmaceuticals Index, prior to any fund-specific fees and expenses. To achieve this, the ETF endeavors to precisely replicate the constituents and their proportionate allocations within that index, striving for a performance correlation of at least 95%.
Updated on Aug 8 2026, 4:00 AM
Company Data
Name FIRST TRUST NASDAQ PHARMACEUTICALS ETF
Company First Trust Nasdaq Pharmaceuticals ETF
Symbol FTXH
Primary Exchange
NASDAQ
NASDAQ
ISIN US33738R8372
Asset Class ETF
Sector Financial Services
Industry Asset Management
Market Capitalization 1 Mrd.
Country United States
Currency USD
Employees -
IPO Date 2016-09-22
Dividends from 'FIRST TRUST NASDAQ PHARMACEUTICALS ETF'
| Ex-Date | Dividend per Share |
|---|---|
| 25.06.2026 | 0,09 USD |
| 26.03.2026 | 0,06 USD |
| 12.12.2025 | 0,13 USD |
| 25.09.2025 | 0,15 USD |
| 26.06.2025 | 0,09 USD |
| 27.03.2025 | 0,10 USD |
| 13.12.2024 | 0,13 USD |
| 26.09.2024 | 0,12 USD |
| 27.06.2024 | 0,13 USD |
| 21.03.2024 | 0,07 USD |
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | FTXH |